Perk Labs Inc.
PERK
CNSX
| 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 7.50K | 29.00K | 2.00K | 8.30K | 4.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.50K | 29.00K | 2.00K | 8.30K | 4.20K |
| Cost of Revenue | 6.70K | 29.00K | 1.10K | 6.60K | 3.20K |
| Gross Profit | 700.00 | 0.00 | 900.00 | 1.70K | 1.00K |
| SG&A Expenses | 355.30K | 389.00K | 11.80K | 306.00K | 370.90K |
| Depreciation & Amortization | 900.00 | 12.40K | 17.60K | 17.60K | 18.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 452.60K | 537.60K | 108.40K | 432.20K | 495.20K |
| Operating Income | -445.10K | -508.60K | -106.40K | -423.90K | -491.00K |
| Income Before Tax | -443.90K | -509.30K | -113.00K | -415.60K | -690.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -443.90K | -509.30K | -113.00K | -415.60K | -690.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -443.90K | -509.30K | -113.00K | -415.60K | -690.90K |
| EBIT | -445.10K | -508.60K | -106.40K | -423.90K | -491.00K |
| EBITDA | -444.30K | -507.70K | -106.20K | -423.70K | -472.60K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 416.22M | 401.67M | 205.60M | 201.67M | 193.66M |
| Average Diluted Shares Outstanding | 469.84M | 441.72M | 205.60M | 201.67M | 193.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |